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  31 
Abstract 32 
 33 
There is evidence that oat β-glucan lowers appetite and ad libitum eating; however, not all 34 
studies are consistent, and the underpinning mechanisms are not entirely understood. We 35 
investigated the effects of 4 g high molecular weight (MW) oat β-glucan on ad libitum eating, 36 
subjective appetite, glycemia, insulinemia and plasma GLP-1 responses in 33 normal-weight 37 
subjects (22 female/11 male, mean age (y): 26.9 ± 1.0, BMI (kg/m2): 23.5 ± 0.4). The study 38 
followed a randomised double-blind, cross-over design with subjects fed two test breakfasts 39 
with and without oat β-glucan followed by an ad libitum test meal on two different days. Blood 40 
samples and ratings for subjective appetite were collected postprandially at regular time 41 
intervals.  Oat β-glucan increased feelings of fullness (p=0.048) and satiety (p=0.034), but did 42 
not affect energy and amount eaten at the ad libitum test meal. There was a treatment by time 43 
interaction for plasma GLP-1, plasma insulin and blood glucose. GLP-1 was significantly 44 
reduced at 90 min (p=0.021), blood glucose at 30 min (p=0.008) and plasma insulin at 30 and 45 
60 min (p=0.002 and 0.017, respectively) following the oat β-glucan breakfast when compared 46 
with the control breakfast. Four grams of high MW oat β-glucan lowers appetite but not ad 47 
libitum eating and beneficially modulates postprandial glycaemia, it does however, not increase 48 
plasma GLP-1 secretion 49 
 50 
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Introduction 52 
Obesity is a worldwide epidemic. For example, the proportion of adults in the United Kingdom 53 
who are either overweight or obese is around 65%, according to the most recent findings (NCD 54 
Risk Factor Collaboration 2017). Not only does obesity significantly increase the risk of Type 55 
2 Diabetes Mellitus, it also poses challenges to the management of diabetes after diagnosis (Lin 56 
et al., 2015). To combat obesity and its comorbidities from a nutrition perspective, research has 57 
focussed on increasing the satiating power of the diet so that individuals feel full with fewer 58 
calories consumed (Astrup, 2005).  59 
 60 
A number of studies suggest that high fibre consumption is associated with increased satiation 61 
and/or satiety (Wanders et al., 2011; Poutanen et al. 2017), lower body weight (Slavin, 2005), 62 
and improved postprandial glycemia (Yuan et al., 2014). There is evidence that increased fibre 63 
consumption not only reduces energy density of ingested food (Heaton et al., 1973; Rolls et 64 
al., 1999) but exerts a direct inhibitory effect on eating (Wanders et al., 2011; Pereira & 65 
Ludwig, 2001; Ibarra et al., 2014). The effect appears to depend on the chemical structure and 66 
the physicochemical properties of the fibre type, i.e. fibre viscosity, water-holding capacity and 67 
fermentability, rather than on total fibre intake (Wanders et al., 2011). Although the inhibitory 68 
effect varies depending on the study population, type, dose and mode of fibre administered as 69 
well as the timing of food intake assessment relative to treatment (Zaremba et al., 2017), several 70 
studies suggest that fibre viscosity is the dominant characteristic that determines the satiating 71 
effect (Clark and Slavin, 2013; Wanders et al., 2011). 72 
 73 
Cereal oat and barley β-glucan consists of high molecular weight polysaccharides that exhibit 74 
high viscosity at low concentrations, consumption of which has been shown to effectively blunt 75 
glycaemic responses by increasing the viscosity of the contents of the upper gastrointestinal 76 
(GI) tract (Wanders et al., 2011), hence, slowing gastric emptying and glucose absorption 77 
(Marciani et al. 2001). There is a positive non-linear relationship between molecular weight 78 
and viscosity, with the molecular weight of beta-glucan being subject to cultivar variety, 79 
growing conditions, processing and storage. The molecular weight of purified oat beta glucan 80 
is in the range of 50 – 3000 kDa (Ajithkumar et al., 2005) but is decreased by food preparation 81 
such as bread-making or further extrusion that impacts bioactivity of cereal β-glucan (Tosh et 82 
al., 2008; Tosh et al., 2010; Wang and Ellis, 2014). The glucose lowering characteristics of β-83 
glucan from oat and barley have been approved by the European Food Safety Authority (EFSA) 84 
with a condition of use health claim that 4 g of β-glucan for each 30 g of available carbohydrate 85 
be consumed per meal to obtain the claimed effect (EFSA, 2011). 86 
 87 
The evidence that cereal β-glucan lowers appetite and ad libitum eating is less conclusive, and 88 
the underpinning mechanisms are not entirely understood. While increased oral exposure time, 89 
stomach distention and colonic fermentation with increased production of short chain fatty 90 
acids (SCFA) may contribute to the satiating effect (Byrne et al., 2015; Wanders et al., 2013, 91 
Kristensen and Jensen, 2011), the role of GI hormones with hypothesized roles in appetite 92 
(Steinert et a., 2017) remains controversial. Some studies report postprandial reductions in 93 
ghrelin (Vitaglione et al., 2009) and increases in cholecystokinin (CCK) and peptide YY (PYY) 94 
(Vitaglione et al., 2009; Beck et al., 2009a; Beck et al., 2009b), while others found no effects 95 
on PYY (Weickert et al., 2006) and glucagon-like peptide-1 (GLP-1) (Ames et al., 2015a). 96 
Moreover, although one study suggested that PYY secretion was increased by more viscous 97 
foods (Beck et al., 2009b), another study found that PYY, CCK and GLP-1 responses were 98 
lower after a highly viscous oat bran drink compared with an identical test drink with reduced 99 
natural viscosity due to β-glucanase treatment (Juvonen et al., 2009). 100 
 101 
In order to better understand the satiating capacity of oat β-glucan and its underpinning 102 
mechanisms, we aimed to investigate the effect of 4 g of high MW oat β-glucan incorporated 103 
into a breakfast meal on ad libitum eating following a 150 min intermeal interval as well as on 104 
subjective feelings of appetite, postprandial glycemia, insulinemia and plasma GLP-1, the latter 105 
because of its central role in both appetite and glycaemic control. We hypothesised that the oat 106 
β-glucan containing breakfast would increase fullness and satiety and decrease ad libitum 107 
eating more than the isocaloric control breakfast, and that this would be accompanied by 108 
increases in plasma GLP-1 and reductions in blood glucose and plasma insulin. 109 
110 
Materials and methods 111 
Subjects 112 
A sample size calculation was conducted for the primary outcome measure of energy intake. 113 
Comparable cross-over trials showed a decrease in energy intake at ad libitum lunches of 114 
between 85 to 170kcal, which varied depending on a number of factors, such as dose of ingested 115 
β-glucan, inter-meal intervals, subject characteristics, and test-meal compositions. For 116 
example, in a study by Vitaglione et al. (2009) a 3 g β-glucan intervention at breakfast reduced 117 
ad libitum lunch energy intake after 3 hours by 170 kcal; whereas Rebello et al. (2016a) 118 
reported a reduction of 85 kcal at an ad libitum lunch following 2.68 g of oat β-glucan 119 
consumption. Using an average standard deviation of 200 kcal and assuming a conservative 120 
decrease in energy intake of 100 kcal, the resulting expected effect size was 0.5. The resulting 121 
minimum sample size was estimated to be n=32-34 (one sample t-test, α = 5%, power of 80%: 122 
nQueryAdvisor 7.0).  123 
 124 
Of the 43 subjects enrolled in the study, there were seven withdrawals due to participant time 125 
constraints, and these were not included in the analysis. Of the 36 subjects who completed the 126 
study, a further three subjects did not adhere to the study protocol, and therefore, were excluded 127 
from data analysis (two subjects did not consume all of the test breakfasts and one subject 128 
arrived at both study mornings with elevated fasted blood glucose). Of the remaining 33 129 
subjects, 22 were female and 11 were male (age 26.9 ± 1.0 years; weight 68.1 ± 2.0kg; BMI 130 
23.5 ± 0.4 kg/m2; waist circumference 78.0 ± 1.5cm). Before inclusion in the study, potential 131 
subjects were briefed and given the opportunity to ask questions. This was followed by a health 132 
assessment, including anthropometric measurements, vital signs, and a general health 133 
questionnaire which gave details of food allergies, metabolic disease, weight changes and 134 
smoking habits. Eating behaviour was determined using the Dutch Eating Behaviour 135 
Questionnaire (van Strein et al., 1986). Restrained eaters were not eligible for participation. 136 
Those also excluded were breakfast skippers, postmenopausal, pregnant or lactating females, 137 
smokers, dieters or those taking medications which may affect appetite. Prior to enrolment, 138 
fasted glucose and haemoglobin measurements were checked to exclude subjects with glucose 139 
impairment (>5.6 mmol/L) and/or anaemia (<120 g/L for females and <130 g/L for males). 140 
Subjects were required to be willing to allow blood collections and not have food allergies to 141 
test meal ingredients (gluten, lactose). Ethical clearance was granted by Queen Margaret 142 
University Research Ethics Committee, Edinburgh, where the research was conducted. 143 
Participants were recruited from Musselburgh, East Lothian and surrounding areas. Written 144 
informed consent was obtained from all subjects. The trial was registered on ClinicaTrials.gov 145 
with registration number NCT02637388. 146 
 147 
Experimental design  148 
The study followed a randomised double-blind, cross-over design with subjects fed two test 149 
breakfasts with and without oat β-glucan followed by an ad libitum test meal on two different 150 
days. There was at least one week between individual study sessions and subjects were required 151 
to complete both sessions within 4 weeks. Each subject was scheduled to arrive at the same 152 
time and on the same day of the week for each treatment and instructed to abstain from 153 
strenuous exercise, alcohol and coffee consumption 24 h prior to treatments. Food diaries 154 
completed 24 h before each treatment showed no differences in energy intakes the day before 155 
study sessions (1845 ± 95 kcal and 1851 ± 115 kcal prior to control and oat β-glucan breakfast, 156 
p=0.94 respectively). Each participant arrived fasted (for 10 hours) at the laboratory between 157 
8:30am and 10:00am during weekdays.  158 
 159 
On each occasion, an antecubital vein catheter was inserted for blood collection (for plasma 160 
insulin and GLP-1) while blood glucose was quantified using a finger-prick blood test. Only 161 
subjects with complete data sets/blood samples were included in analysis for GLP-1 and 162 
insulin. After taking a fasted blood sample, subjects consumed the test breakfast within 10 min. 163 
 164 
The breakfast consisted of Kellogg’s Rice Krispies cereal (Kellogg Company, Manchester, 165 
UK), with semi skimmed milk (1.8 % fat) and Greek-style yoghurt (Tesco Groceries, 166 
Edinburgh, UK). Four grams of high MW oat β-glucan (from 14.6 g of OatWell Original 167 
Powder, DSM Nutritional Products Ltd., Kaiseraugst, Switzerland) was split between the cereal 168 
and Greek-style yoghurt to improve palatability of the breakfast. For this, 7.3g OatWell powder 169 
was mixed with Greek-style yoghurt and 7.3g OatWell powder was mixed with dry Rice 170 
Krispies in a bowl before semi-skimmed milk (150 mL) was poured over the Rice Krispies by 171 
the subject immediately before commencing the meal. Tosh et al. (2010) previously determined 172 
the MW of OatWell™ oat β-glucan to be 2.213 x106 g mol-1.  173 
 174 
A researcher who was not involved in the study was responsible for assigning the order of the 175 
two breakfasts (with and without oat β-glucan) using a random number generator (Microsoft 176 
Excel) and supervised the subjects whilst eating. Subjects were required to finish the breakfast 177 
within 10 minutes and afterwards to rate the palatability of both breakfasts using a VAS. The 178 
breakfasts were matched for their protein, fat and carbohydrate contents: 1) in order 179 
accommodate for the energy content of the oat bran powder, the Greek-style yoghurt was 180 
reduced by 10 g in the intervention breakfast. In order to adequately match protein and CHO 181 
contents of both breakfasts, 28 mL of PROmilk50 (ready-to-drink vanilla protein milk, 182 
MyProtein, Cheshire, UK) was added to the control breakfast (Table 1).  183 
 184 
After the breakfast, additional blood samples for measurement of plasma insulin and GLP-1 185 
and blood glucose were collected at intervals of 30 min (t=0-90) and VAS were completed at 186 
intervals of 15 min (t = 0-150 min). At t = 150 min, each subject was then offered an ad libitum 187 
test meal and allowed to consume as much food and water as desired until reaching comfortable 188 
fullness, for a maximum of 30 min (t = 150–180 min).  189 
 190 
The meal consisted of ham sandwiches, made from white sliced bread (approximately 40 g per 191 
slice, Hovis medium soft white, High Wycombe, UK), butter (10 g per slice, Countrylife, 192 
Surrey, UK) and sliced cooked ham (approximately 45 g per sandwich, Tesco Groceries, 193 
Edinburgh, UK). Nutritional composition of the ham sandwiches was 10.3 g of protein, 11.7 g 194 
of fat, 23.9 g of carbohydrate with 243 kcal, all per 100 g. The sandwiches were cut into four 195 
equal-sized pieces and served in excess to the subject along with water.  Subjects were told to 196 
eat until they felt ‘comfortably full’ and to complete a food diary for the remainder of the day 197 
(i.e. from when they left the laboratory until when they stopped eating at night). Plate waste 198 
and water left over were weighed after the subject left the laboratory. 199 
 200 
Measurements: 201 
Appetite and food intake: Perceptions of hunger, fullness, desire to eat, satiety and prospective 202 
food consumption were measured using validated VAS (Blundell et al., 2010). Each VAS was 203 
composed of lines 100 mm in length anchored by the descriptors not at all to extremely. Food 204 
intake at the test meal was calculated from the amount of food (g) eaten at the ad libitum meal. 205 
Energy intake (kcal) and macronutrient composition (expressed as g and % of energy) were 206 
then calculated using Nutritics dietary assessment software (version 4.0, Nutritics Ltd., Dublin, 207 
Ireland). 208 
 209 
Blood glucose and plasma insulin and glucagon-like peptide (GLP-1): Finger-prick blood 210 
glucose measurements were taken using a sterile lancet device (Accu-Chek Safe T Pro Plus, 211 
Roche Diagnostics, UK) and quantified by an Accu-Check Aviva glucometer (Roche 212 
Diagnostics, UK). Blood samples for total GLP-1 and insulin measurements were collected in 213 
lavender capped BD Vacutainer® plastic K2EDTA tubes (BD Diagnostics, US). The tubes 214 
were placed on ice and centrifuged at 3,000 x rpm (Thermo Scientific Heraeus Biofuge Primo 215 
R) for 15 min at 4 °C. Plasma samples were aliquoted into cryogenic eppendorf tubes and 216 
stored at −85 °C until analysis. Plasma concentrations of total GLP-1 (intra-coefficient of 217 
variation (CV): <5 %; inter-CV: <12 %; 1.5 pM sensitivity as per Millipore, CAT# EZGLP1T-218 
36K) and insulin (intra-CV: 4.6–7.0 %; inter-CV: 9.1–11.4 %; 1 µU/mL sensitivity as per 219 
Millipore, CAT# EZHI-14K) were measured using ELISA kits (Merck, Germany). A 220 
quantitative curve fitting program for immunoassays (MasterPlex 2010), which used a 5 221 
Parameter Logistic model equation, was used to compute standard curves and determine insulin 222 
and total GLP-1 concentrations. 223 
 224 
Test food viscosity: A constant shear rheometer, Bohin Rheometer C-VOR 150 (Malvern Bohin 225 
Instruments), fitted with a 4o /40 mm diameter cone and plate geometry, was used for all 226 
viscosity measurements. Measurements were carried out at 37oC to mimic stomach temperature 227 
and at shear rates ranging from 0.5x10-1 to 1.0x102 s-1.  228 
 229 
Data and statistical analysis 230 
Statistical analysis was performed using SPSS software (version 23.0; Chicago, IL, USA). 231 
Normality of all data were tested using Shapiro–Wilk statistic. Differences in energy intake 232 
between the two treatments were assessed using Students paired samples t-test. Total area 233 
under the curves (AUC) for subjective appetite ratings, blood glucose and hormones were 234 
calculated using the trapezoidal method. Subjective appetite ratings were analysed using 235 
ANCOVA with baseline values used as co-variate (Blundell et al., 2010). Time x treatment 236 
effects for blood glucose and hormones were identified using a two-factor analysis of variance 237 
(2 factor-ANOVA) with time and treatment (breakfast) as factors. Post hoc comparisons, 238 
adjusted for multiple comparisons by Bonferroni’s correction, were performed where 239 
ANOVAs revealed significant effects to identify differences between treatments across 240 
timepoints. All tests were two tailed and significance was set at p<0.05. All values are presented 241 
as means ± standard error of the mean (SEM). 242 
  243 
Results 244 
There was no effect of treatment on ad libitum eating. Total intakes at the test meal were 681 245 
± 46 kcal and 267 ± 18 g with the breakfast containing oat β-glucan and 704 ± 51 kcal and 275 246 
± 20 g with the control breakfast (t(32)=0.875, p=0.388 and t(32)=0.846, p=0.404, 247 
respectively). The oat β-glucan breakfast also did not detectably affect subjects’ energy intake 248 
for the remainder of the study day when compared with the control breakfast (t(31)=-1.70, 249 
p=0.099, Table 2). There was also no difference in water intake at the ad libitum meal (t(32)=-250 
0.32, p=0.751, Table 2). 251 
 252 
There was a significant effect of oat β-glucan breakfast on total AUC of satiety ratings after 253 
controlling for baseline AUC, (F[1,60]=3.07, p=0.034. Total AUC for satiety following oat β-254 
glucan and control breakfast were 7604 ± 459 mm x min and 6516 ± 427 mm x min, 255 
respectively. There was also a significant effect on total AUC of fullness ratings after 256 
controlling for baseline AUC, (F[1,60]=2.98, p=0.048. Total AUC for fullness following oat 257 
β-glucan and control breakfast were 7563 ± 428 mm x min and 6505 ± 453 mm x min, 258 
respectively (Figure 1). There was no effect of oat β-glucan on hunger (p=0.133), desire to eat 259 
(p=0.098) or prospective food consumption (p=0.213). 260 
 261 
There were no differences in baseline (fasting) values between study days for total GLP-1 262 
(t(20)=-1.76, p=0.09, blood glucose (t(32)=0.29, p=0.771), or plasma insulin (t(20)=-1.40, 263 
p=0.176, Figure 2). 264 
 265 
For plasma GLP-1, Mauchly’s Test of Sphericity indicated that the assumption of sphericity 266 
had been violated, X2(5) = 9.59, p=0.03, and therefore, a Greenhouse Geisser correction was 267 
used. There was a treatment x time interaction (F[2.3,45.3]=6.62, p=0.002) for GLP-1. Plasma 268 
GLP-1 concentrations were significantly reduced at 90 min after the oat β-glucan breakfast 269 
when compared with the control breakfast (22 ± 9 pmol/L vs. 17 ± 9 pmol/L, t(20)=2.50, 270 
p=0.021, Figure 2A). There was no significant difference for GLP-1 AUCs between treatments 271 
(t(20)=0.59, p=0.56, Table 3). Only subjects with complete data sets were included in the 272 
analysis for plasma GLP-1 (full data, n=21). 273 
 274 
For blood glucose, Mauchly’s Test of Sphericity indicated that the assumption of sphericity 275 
had been violated, X2(5) = 16.78, p=0.005, and therefore, a Greenhouse Geisser correction was 276 
used. There was a treatment x time interaction (F[2.3,72.3]=49.13, p<0.001) for blood glucose. 277 
Blood glucose was significantly lower at 30 min after the oat β-glucan breakfast when 278 
compared with control (6.0 ± 1.0 mmol/L vs. 6.5 ± 0.9 mmol/L (t(32)=2.81, p=0.008, Figure 279 
2B)). There was no significant difference for blood glucose AUCs between treatments 280 
(t(32)=1.21, p=0.235, Table 3).  281 
 282 
For plasma insulin, Mauchly’s Test of Sphericity indicated that the assumption of sphericity 283 
had been violated, X2(5) = 12.2, p=0.033, and therefore a Greenhouse Geisser correction was 284 
used. There was a treatment x time interaction (F[2.08,44.1]=56.98, p<0.001) for plasma 285 
insulin. Plasma insulin was significantly lower at 30 and 60 min after the oat β-glucan breakfast 286 
when compared with control (32.4 ± 18 µU vs. 50.3 ± 23.1 µU, t(20)=3.63, p=0.002 and 15.8 287 
± 9.2 µU vs. 24.4 ± 18 µU, (t(20)=2.62, p=0.017, respectively, Figure 2C). The AUC for 288 
insulin over the 90 min period was also significantly lower following the oat β-glucan breakfast 289 
when compared with the control breakfast (t(20)=3.99, p=0.001, Table 3). Only subjects with 290 
complete data sets were included in the analysis for plasma insulin (full data, n=21). 291 
 292 
The viscosity of the different components of the breakfast containing oat β-glucan was 293 
considerably greater than that of the control breakfast, with significant differences in viscosity 294 
seen at 50s-1 (p<0.001), a shear rate representative of gastric conditions (Figure 3).  295 
 296 
A significant reduction in palatability ratings for the β-glucan breakfast compared to control 297 
breakfast was reported (36.4±4.3 mm and 72.9±3.8 mm, respectively, p<0.001). There were, 298 
however, no significant differences for aftertaste (61.8 ± 4.2 mm, 64.0 ± 4.5 mm, p=0.71) or 299 
smell (52.3 ± 3.5 mm, 59.4 ± 3.8 mm, p=0.07) between breakfasts. 300 
  301 
Discussion 302 
The evidence for oat and barley β-glucans to lower appetite and ad libitum eating is 303 
contradictory and the underpinning mechanisms, particularly GI satiation peptide secretion, 304 
unclear. Here we investigated the effect of high MW oat β-glucan incorporated into a breakfast 305 
meal on ad libitum eating, subjective appetite, plasma GLP-1 and insulin as well as blood 306 
glucose concentrations in 33 healthy subjects. Based on previous studies, we hypothesized that 307 
oat β-glucan increases fullness and/or satiety and reduces ad libitum eating associated with by 308 
increases in plasma GLP-1 and reductions in blood glucose and plasma insulin. We found that 309 
subjects were more satiated and fuller after consuming the oat β-glucan breakfast when 310 
compared to the control; however, in contrast to our hypothesis, this did not translate into a 311 
reduction in food intake either during the ad libitum test meal or for the remainder of the day. 312 
There was also no increase in plasma GLP-1; in contrast, we found a small but significant 313 
decrease 90 min after the breakfast with oat β-glucan. In line with the literature, we observed 314 
significant reductions in postprandial blood glucose and plasma insulin (Tosh 2012). 315 
 316 
The potency of oat and barley β-glucan to modulate appetite has been reported in several 317 
studies, although the effect seems to vary depending on the study design, subject characteristics 318 
(e.g. BMI, sex) and the dose and MW of β-glucan consumed (doses range from 2.2 to 9.4 g 319 
with varying or unreported MWs (Vitaglione et al., 2009; Beck et al., 2009a; Lyly et al., 2009; 320 
Willis et al., 2009; Clegg & Thondre, 2014)). Fullness was increased in 14 healthy overweight 321 
subjects following a 3.82 g dose of β-glucan oat bran cereal with a high MW of 1.378 x 106 322 
gmol-1 consumed at breakfast in a study conducted by Beck et al. (2009a), and similarly by 323 
Pentikainen et al. (2014) following 4 g of high MW β-glucan incorporated into biscuits and 324 
juice consumed at breakfast by normal weight female subjects.  In contrast, Beck et al (2009a) 325 
reported no effect on subjective appetite ratings following a 5.65 g high MW β-glucan 326 
containing breakfast. Our findings are in line with the majority of studies and suggest that oat 327 
β-glucan beneficially modulates appetite by increasing fullness and satiety. 328 
 329 
The manufacturing process such as baking, cooking or extrusion (Hu et al., 2010; Ames et al. 330 
2015b) and other test food characteristics including food matrix and formats may also affect 331 
the satiating capacity of oat β-glucan (Rebello et al., 2014; El Khoury et al., 2012). The 332 
physicochemical properties of the matrix in which the fibre is delivered in combination with 333 
the gut environment play a critical role in determining the hydration or swelling and water-334 
retention capacity of the fibre (Rebello et al., 2016b). In our study, β-glucan was consumed in 335 
a semi-solid food matrix, with yoghurt and cereal with milk used as the vehicle to deliver β-336 
glucan. Other studies that have used a semi-solid food matrix also reported increased satiety 337 
and fullness with test meals containing 1.6 to 4 g oat β-glucan (Rebello et al., 2014; Rebello et 338 
al., 2016a; Geliebter et al., 2015). Juvonen and colleagues (2011), however, found no effect on 339 
subjective appetite following a semi-solid semolina-based pudding that contained 5.1 g oat β-340 
glucan, suggesting that the food matrix alone does not determine oat β-glucan´s satiating 341 
capacity. More research is, thus, warranted to better understand how a fibre’s satiating capacity 342 
depends on experimental paradigms, population characteristics and fibre/food format features. 343 
 344 
The beneficial effect on subjective appetite did not translate into a decrease in food intake at 345 
the ad libitum test meal, which is in line with a number of studies that have reported similar 346 
dissociations following oat β-glucan consumption (Beck et al., 2009a; Clark and Slavin, 2013). 347 
It is important to note that although appetite VAS are generally sensitive to experimental 348 
manipulations and are reproducible, they have failed to predict meal size under a number of 349 
conditions (Beck et al., 2009a; Stubbs et al., 2007; Flint et al., 2000). The magnitude of 350 
differences in self-reported VAS which precede ad libitum eating were investigated recently 351 
by Sadoul et al. (2014) based on a large number of studies that used a wide range of nutrient 352 
preloads. They found that a significant difference in energy intake at lunch was likely to be 353 
achieved if the difference in satiety VAS (intervention vs. control) immediately before the ad 354 
libitum meal was at least 15–25 mm on a 100 mm scale. In our study, differences in satiety 355 
VAS at meal onset 150 min after the preload was only about 10 mm which may possibly 356 
explain the lack of effect on ad libitum eating. Whether a different inter-meal interval or a 357 
higher dose of oat β-glucan or another food matrix may have resulted in significant eating 358 
effects should be investigated more comprehensively, for example, by using varying time 359 
intervals, doses and formats in the same study. Because satiation depends on both gastric and 360 
intestinal nutrient stimulation, and their interactions (Steinert et al., 2017), an optimal dose and 361 
timing between preload and ad libitum test meal is likely crucial to detect an eating-inhibitory 362 
effect. Perhaps the best method may be to have participants select the time of the next meal, 363 
this approach has been scarcely explored. 364 
 365 
Several lines of evidence support the hypothesis that increased gastric volume contributes to 366 
satiation (Steinert et al., 2017). Viscous fibres absorb large quantities of water and most studies 367 
link ingestion of viscous dietary fibres to delayed gastric emptying (Benini et al., 1995; 368 
Bergmann et al., 1992; Marciani et al., 2000, de Graaf et al., 2004), which will increase gastric-369 
volume signals. Bergmann et al (1992), for example, found sensations of satiety and hunger 370 
highly correlated with gastric emptying rates following consumption of viscous psyllium fibre 371 
(r=0.989, p=0.0001). We did not measure gastric emptying in the current study; however, there 372 
are a few studies that report a slowing of gastric emptying with cereal β-glucans under similar 373 
conditions (Juntunen et al., 2002; Geliebter et al., 2015; Yu et al. 2014). 374 
 375 
It has been speculated that because viscous dietary fibres increase the viscosity of digesta in 376 
the small intestine, they prolong small intestinal transit time and absorption rate of nutrients, 377 
which increases contact time with enteroendocrine cells and, thus, peptide release. In addition, 378 
high viscous fibres may disrupt proper mixing of food particles and digestive enzymes, 379 
resulting in an increased delivery of unabsorbed nutrients into distal parts of the small intestine 380 
where the density of GLP-1 and PYY secreting L-cells is highest (Kristensen & Jensen, 2011; 381 
Rebello et al. 2016b). Indeed, Beck and colleagues reported that CCK and PYY increases 382 
linearly with increasing amounts of oat β-glucan (Beck et al., 2009a; Beck et al., 2009b). For 383 
PYY, there was a significant dose response relationship between grams consumed and PYY 384 
AUC (r2 = 0.994, P = 0.003). The effect was most pronounced with doses of 4 to 6 grams at a 385 
late postprandial phase, as a function of both viscosity and concentration (Beck et al., 2009b). 386 
Juntunen et al., (2002) demonstrated an increase in post-prandial GLP-1 at 120 and 150 minutes 387 
following 5.4 g β-glucan-containing rye bread. In contrast, a study by Ames et al., (2015) 388 
reported no effect of barley fibre enriched tortillas on post-prandial GLP-1 secretion, doses of 389 
which ranged from 4.5 g to 11.6 g β-glucan. Moreover, when the natural viscosity of a 300 mL 390 
beverage containing 30 g oat bran concentrate (including 5.1 g soluble fibre) was reduced by 391 
β-glucanase treatment, CCK, PYY and GLP-1 were increased rather than decreased when 392 
compared with the high viscous isocaloric control drink (Juvonen et al., 2009). The high-393 
viscosity beverage was still rated as more filling than control, and although there was no 394 
difference in ad libitum eating this finding suggests that increased viscosity does not favour 395 
CCK, PYY and GLP-1 secretion and that oat bran affects appetite independent of GI peptide 396 
secretion. Our findings are in line with the latter study. We found a small but significant 397 
decrease in plasma GLP-1 at 90 min with oat β-glucan suggesting that (i) high viscous oat β-398 
glucan does not favor activation of enteroendocrine cells and, thus, GLP-1 secretion and (ii) 399 
oat β-glucan beneficially modulates appetite independent of increased plasma GLP-1, at least 400 
under our conditions. Assuming that oat β-glucan slowed gastric emptying 0-90 min after meal 401 
onset, an explanation for the decrease in plasma GLP-1 is provided by studies showing that the 402 
secretion of GLP-1 and other GI peptides is dependent on intestinal caloric load, with higher 403 
loads resulting in larger responses (Pilichiewicz et al., 2007). We can, however, not exclude an 404 
effect on later phase GLP-1 secretion due to increased delivery of unabsorbed nutrients into 405 
distal intestinal parts. 406 
 407 
As expected, consumption of β-glucan at breakfast significantly blunted the post-prandial 408 
blood glucose and insulin responses in line with a large number of previous studies (Tosh 409 
2012). This is most likely due to a delay in gastric emptying and subsequent glucose absorption, 410 
although we did not directly assess this. However, we found that the test meal rich in oat β-411 
glucan showed substantially higher viscosity than the control meal, which supports this 412 
hypothesis.  413 
 414 
There are a number of limitations that require consideration. We did not measure plasma GLP-415 
1 (or other satiation peptide) concentrations >90 min after the breakfast meal and thus can only 416 
speculate about hormone level at ad libitum test meal onset.  Caution should also be taken when 417 
interpreting data for GLP-1 and insulin due to missing data and, thus, smaller sample size. 418 
Moreover, variability in energy intakes may have resulted due to menstrual cycle status 419 
(Asarian and Geary, 2013), which was not monitored or controlled in female subjects in our 420 
study. Finally, palatability ratings of the β-glucan breakfast were lower than the control 421 
breakfast, thus, memory or other cognitive effects may have influenced subsequent eating as 422 
suggested by some studies (Johnson and Vickers, 1992; Yeomans et al., 2001). 423 
 424 
 425 
In conclusion, 4 g of high MW oat β-glucan beneficially modulated appetite with increased 426 
feelings of fullness and satiety but with no effect on ad libitum eating. This is associated with 427 
reduced plasma GLP-1 at 90 min, and a significant reduction in blood glucose and plasma 428 
insulin.  429 
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  615 
 616 
Table 1. Ingredients, energy and macronutrient composition of the breakfasts 617 
 Control β-glucan 
Ingredients 
Kellogg’s Rice Krispies (g) 30 30 
Semi-skimmed milk (1.8% fat) (mL) 150 150 
Greek-style yoghurt (g) 90 80 
Protein milk (mL) 28  - 
OatWell oat bran (g) - 14.6 
Nutrient content 
Total energy (kcal) 319.8 329.1 
Fat g (% of total energy) 11.6 (33) 11.3 (31) 
Carbohydrate g (% of total energy) 39.7 (50) 39 (47) 
Protein g (% of total energy) 13.8 (17) 13.9 (17) 
Fibre (g) 0.3 7.9 
β-glucan (g) 0 4 
Weight (g) 298 274.5 
Nutritional information was taken from nutrient declarations present on product food labels 618 
 619 
 620 
 621 
 622 
Table 2. Food consumed at the ad libitum test meal and for the remainder of the study day 623 
following control and β-glucan breakfasts 624 
 Control β-glucan p-value 
Energy intake at ad libitum test meal 
(kcal) 
704 ± 51 681 ± 46 0.388 
Food quantity at ad libitum test meal (g) 275 ± 20 267 ± 18 0.404 
Water intake at ad libitum test meal 
(mL)  
213 ± 11 218 ± 15 0.751 
Energy intake for the remainder of 
study day (subsequent 12 h) (kcal) 
886 ± 91 1094 ± 120 0.099 
Data are from n=33 subjects except for food intake for the remainder of study days, where 625 
one subject failed to return their food record (n=32). Data are means ± SEM 626 
 627 
 628 
 629 
 630 
 631 
 632 
 633 
 634 
 635 
Table 3. Area under the curves (AUC) for blood glucose and plasma insulin and total GLP-1 636 
concentrations following control and β-glucan breakfasts 637 
 Control β-glucan p-value 
Glucose AUC (mmol x L-1 x min-1) 498.2 ± 47.3 483.0 ± 49.5 0.235 
Insulin AUC (µU x mL-1 x min-1) 2491.0 ± 1211 1682.2 ± 902.4 0.001 
Total GLP-1 AUC (pmol x L-1 x min-1) 1732.7 ± 713 1654.7 ± 706.8 0.560 
Data are from n=33 subjects for blood glucose and n=21 for plasma insulin and total GLP-1. 638 
AUC based on 0-90 min data. Data are means ± SEM 639 
  640 
Figure 1 641 
  642 
Figure 2 643 
 644 
 645 
646 
Figure 3  647 
 648 
 649 
  650 
Figure legends: 651 
 652 
Figure 1 Visual analogue scales (VAS) for subjective ratings of fullness (A) and satiety (B) 653 
during the 150-min postprandial period following control (●) and β-glucan (□) breakfast 654 
consumption. Data were analysed by ANCOVA using baseline value as co-variate. Data are 655 
means ±SEMs (n=31, two subjects were excluded from data analysis as they misunderstood 656 
the VAS questionnaires).  657 
 658 
Figure 2 Plasma glucagon-like peptide-1 (A), blood glucose (B), and plasma insulin (C) 659 
concentrations during the 90-min postprandial period following control and β-glucan breakfast 660 
consumption. Data were analysed with two-factor ANOVA, with treatment and time as factors. 661 
In case of significant differences, post hoc comparisons, adjusted for multiple comparisons by 662 
Bonferroni correction, were performed to determine significant differences between the control 663 
(●) and β-glucan (□) breakfasts. *p<0.05. Data are means ±SEMs (A, n=33; B and C, n=21, 12 664 
subjects were excluded from the analysis due to incomplete data sets). 665 
 666 
Figure 3 Viscosity of both, the yoghurt (A) and milk (B) component of the test meal containing 667 
high-molecular weight oat β-glucan (□) or control (●) across different shear rates ranging from 668 
0.5x10-1 to 1.0x102 s-1. Inserts depict a shear rate of 50s-1, representative of gastric conditions. 669 
*p<0.05  670 
